Insider · CIK 0002094941
Weegen Felice Isabel Verduyn-van
Files at EVMN (Evommune, Inc.). First filing Nov 12, 2025, latest Nov 12, 2025.
Weegen Felice Isabel Verduyn-van files SEC Form 4 as director and 10% owner at EVMN (Evommune, Inc.). Since Nov 12, 2025, Weegen Felice Isabel Verduyn-van has reported 1 open-market buy worth $25M and 0 open-market sells worth $0, the latest filed on Nov 12, 2025.
A track record needs three past buys with six months of prices behind them; Weegen Felice Isabel Verduyn-van has 0, so none is measured yet.
The newest scored trade: bought $25M of EVMN on Nov 7, 2025, filed Nov 12, 2025, scored 61 (notable). In the last 12 months: 1 buy worth $25M and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
EVMN: Evommune, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 61Notable | Evommune, Inc. | $25M 1,562,500 shares | +46% | - |
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 17, 2026 | EVMN Evommune, Inc. | AGrant or award Common Stockindirect: By LSP 7 Cooperatief U.A. | +358,680 | $27.88 | $10.0M | 5,288,313 | Feb 18, 2026 |
| Nov 7, 2025 | EVMN Evommune, Inc. | CConversion Common Stockindirect: By LSP 7 Cooperatief U.A. | +3,367,133 | - | - | 3,367,133 | Nov 12, 2025 |
| Nov 7, 2025 | EVMN Evommune, Inc. | POpen-market purchase Common Stockindirect: By LSP 7 Cooperatief U.A. | +1,562,500 | $16.00 | $25M | 4,929,633 | Nov 12, 2025 |
| Nov 7, 2025 | EVMN Evommune, Inc. | CConversion Series A Preferred Stockderivativeindirect: By LSP 7 Cooperatief U.A. | -15,493,466 | - | - | 0 | Nov 12, 2025 |
| Nov 7, 2025 | EVMN Evommune, Inc. | CConversion Series B Preferred Stockderivativeindirect: By LSP 7 Cooperatief U.A. | -5,090,000 | - | - | 0 | Nov 12, 2025 |
| Nov 7, 2025 | EVMN Evommune, Inc. | CConversion Series C Preferred Stockderivativeindirect: By LSP 7 Cooperatief U.A. | -6,585,011 | - | - | 0 | Nov 12, 2025 |
Questions about Weegen Felice Isabel Verduyn-van
Answered from the filings on this page, as of the latest one.
Is Weegen Felice Isabel Verduyn-van buying or selling?
In the last 12 months Weegen Felice Isabel Verduyn-van reported 1 open-market buy worth $25M and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $25M of EVMN on Nov 7, 2025. Grants, option exercises and tax withholding are not counted.
How did Weegen Felice Isabel Verduyn-van's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Weegen Felice Isabel Verduyn-van has 0.
Where does Weegen Felice Isabel Verduyn-van file Form 4?
Weegen Felice Isabel Verduyn-van has filed Form 4 at EVMN (Evommune, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.